ILLUMINA, INC. Marketable Securities, Unrealized Gain (Loss)
ILLUMINA, INC. (ILMN) reported Marketable Securities, Unrealized Gain (Loss) of -$42.00 million for the 3-month period ending 2022-04-03, per its 10-Q filed 2022-05-05.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2022-05-05
- ILLUMINA, INC. marketable securities, unrealized gain (loss) for the quarter ending 2022-04-03 was -$42.00M.
- ILLUMINA, INC. marketable securities, unrealized gain (loss) for the quarter ending 2022-01-02 was $53.00M, a 62.68% decline year-over-year.
- ILLUMINA, INC. marketable securities, unrealized gain (loss) for the quarter ending 2021-10-03 was $45.00M, a 23.73% decline year-over-year.
- ILLUMINA, INC. marketable securities, unrealized gain (loss) for the quarter ending 2021-07-04 was -$3.00M, a 104.55% decline year-over-year.
- ILLUMINA, INC. marketable securities, unrealized gain (loss) for fiscal 2022 was $37.00M, a 86.30% decline from fiscal 2021.
- ILLUMINA, INC. marketable securities, unrealized gain (loss) for fiscal 2021 was $270.00M, a 409.43% increase from fiscal 2019.
- ILLUMINA, INC. marketable securities, unrealized gain (loss) for fiscal 2019 was $53.00M, a 152.38% increase from fiscal 2018.
- ILLUMINA, INC. marketable securities, unrealized gain (loss) for fiscal 2018 was $21.00M.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2022-04-03 | -$42.00M 10-Q · filed 2022-05-05 | $11.00M derived: sum of 2 quarters · filed 2022-05-05 | $56.00M derived: sum of 3 quarters · filed 2022-05-05 | $53.00M derived: sum of 4 quarters · filed 2022-05-05 |
| 2022-01-02 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $98.00M derived: sum of 2 quarters · filed 2022-02-18 | $95.00M derived: sum of 3 quarters · filed 2022-02-18 | $37.00M 10-K · filed 2022-02-18 |
| 2021-10-03 | $45.00M 10-Q · filed 2021-11-05 | $42.00M derived: sum of 2 quarters · filed 2021-11-05 | -$16.00M 10-Q · filed 2021-11-05 | $126.00M derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-07-04 | -$3.00M 10-Q · filed 2021-08-06 | -$61.00M 10-Q · filed 2021-08-06 | $81.00M derived: sum of 3 quarters · filed 2022-05-05 | $140.00M derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-04-04 | -$58.00M 10-Q · filed 2022-05-05 | $84.00M derived: sum of 2 quarters · filed 2022-05-05 | $143.00M derived: sum of 3 quarters · filed 2022-05-05 | $209.00M derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-01-03 | $142.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $201.00M derived: sum of 2 quarters · filed 2022-02-18 | $267.00M derived: sum of 3 quarters · filed 2022-02-18 | $270.00M 10-K · filed 2022-02-18 |
| 2020-09-27 | $59.00M 10-Q · filed 2021-11-05 | $125.00M derived: sum of 2 quarters · filed 2021-11-05 | $128.00M 10-Q · filed 2021-11-05 | $124.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-28 | $66.00M 10-Q · filed 2021-08-06 | $69.00M 10-Q · filed 2021-08-06 | $65.00M derived: sum of 3 quarters · filed 2022-02-18 | $112.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-29 | $3.00M 10-Q · filed 2021-04-28 | -$1.00M derived: sum of 2 quarters · filed 2022-02-18 | $46.00M derived: sum of 3 quarters · filed 2022-02-18 | $148.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-29 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $43.00M derived: sum of 2 quarters · filed 2022-02-18 | $145.00M derived: sum of 3 quarters · filed 2022-02-18 | $53.00M 10-K · filed 2022-02-18 |
| 2019-09-29 | $47.00M 10-Q · filed 2020-10-30 | $149.00M derived: sum of 2 quarters · filed 2020-10-30 | $57.00M 10-Q · filed 2020-10-30 | $172.00M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-30 | $102.00M 10-Q · filed 2020-08-07 | $104.00M 10-Q · filed 2020-08-07 | $125.00M derived: sum of 3 quarters · filed 2021-02-17 | |
| 2019-03-31 | $2.00M 10-Q · filed 2020-05-01 | $23.00M derived: sum of 2 quarters · filed 2021-02-17 | ||
| 2018-12-30 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $21.00M 10-K · filed 2021-02-17 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-10-25 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |